Canadian Institutes of Health Research
Government of Canada Symbol
Skip to content Skip to institutional links

Common menu bar links

Home > Funding Overview >

 

Health Research Partnership Fund (2004) (Archived)

Applicants to CIHR's open competition may be interested in also indicating one of the partner programs below. Organizations below partner with CIHR through the Health Research Partnership Fund to provide additional training opportunities through the open competition.

The Health Research Partnership Fund (HRPF) is CIHR's primary vehicle for fostering partnership opportunities with small not-for-profit agencies to support training awards in specific targeted areas of health research. Partner organizations identify the area(s) of health research relevant to their mission, strategic direction or interest and CIHR provides an internationally recognized peer-review process and administrative program support.

CIHR will fully fund all research scoring above its regular funding threshold. CIHR and the partners will pay for meritorious awards identified by the partner as relevant to their research area and scoring below the CIHR funding threshold but above merit cut-off (3.5). Only the awards above the CIHR funding threshold will count towards CIHR's contribution to the partnership. All the awards above and below the CIHR funding threshold will hold both the name of the partner and CIHR.

The following training programs are offered under the HRPF:

  1. Doctoral Research Awards
  2. Fellowships


Eligibility

Applicants should review the General Guidelines for All Research Training Awards as well as the CIHR Doctoral Research Awards and/or Fellowships program descriptions. Both are found within the CIHR Research Personnel Awards Guidelines.

Eligibility criteria for all CIHR research funding (grant) programs apply. The business office of the institution of an eligible Nominated Principal Applicant general administers CIHR funds. Please refer to the General Grants and Awards Policies under CIHR's Grants and Awards Guides on the CIHR website, regarding the eligibility requirements for individuals and institutions.

Candidates must:

  1. follow the general guidelines for CIHR training awards for eligibility requirements and application procedures. Applications are to be submitted to CIHR using the appropriate application package. Applicants must use the CIHR web-based forms. A Personal Identification Number (PIN) must be obtained to enable access to these forms. A copy of the application forms are also available to be downloaded in PDF format. The following modules are required: CIHR Training module, and Common CV module, validated for CIHR . Applicants are advised to refer to the "Guidelines for Completion" specific to each application module, and the instructions on "How to Apply" including the applicable section of the Grants and Awards Guide.
  2. adhere to any special conditions placed on the award (see information for each organization), and
  3. clearly propose a training program relevant to the partners' stated interests as described below.

General CIHR Guidelines and Conditions of Funding

All conditions, as specified in CIHR's General Grants and Awards Policies shall apply to grants funded through this initiative. Conditions cover areas such as Applicant and Institutional Responsabilities, Ethic, Official Language Policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.

Funding

Unless otherwise stipulated as a special condition, the period of support is based on the general guidelines for CIHR training programs (unless otherwise stated by the partner) and on peer review recommendations. The value of the award will be in accordance with the regular CIHR stipends.

If, at any time during the tenure of the award, the supervisor feels that the progress of the trainee is not satisfactory, the CIHR and/or the partner must be notified immediately in writing.

Applications

Applications are to be submitted to CIHR using the appropriate application modules which are available on the CIHR website. To ensure that the application is forwarded to the appropriate CIHR staff, in the Program section of the CIHR Training Module Webform (page 3 of the PDF form), check off the box beside "Partnership Program" and in the space provided indicate the appropriate partnership (i.e. Organization X/CIHR partnership). CIHR will forward a copy of the application directly to the Partner.

Applicants should review the application guidelines in the Grants and Awards Guide available on CIHR's website.

Peer Review

Applications will be reviewed by both CIHR and the Partner. The Partner will determine the relevance of the candidates' research objectives to the Partners' stated research interests. Applications will be peer reviewed, in accordance with CIHR's peer review process, in terms of scientific standards. Successful candidates will be selected and approved by both the Partner and CIHR..

Key Dates:


Doctoral Research Award: October 15, 2004
Fellowship: October 1, 2004

Effective Date

Awards must be taken up within 12 months of the date of the offer, and may commence on the first day of any month.

Communications

The recipient of the award must acknowledge the contribution of the Partner and CIHR, as a source of their funding and research outcomes, and in all communications activities including publications, media, symposia, research reports, and any promotional events.

Program Performance Measurement and Evaluation

CIHR has made plans to assess performance of this initiative through ongoing monitoring and periodic evaluation. We are committed to informing Canadians about the performance of our initiatives and the results that they deliver.

All funded applicants will be expected to participate in the evaluation strategy, contributing advice data and reports as required for assessment purposes.

Research Agenda - Capacity Building

(Note: This list will continue to expand as Partners come on board to participate in the program. Keep referring to the list for updates until mid-September, 2004.)

Partner Research Area(s)
Canadian Fanconi Anemia Research Fund Fanconi Anemia (FA).
Fragile X Research Foundation of Canada Fragile X research
Canadian Foundation Louis Pasteur Infectious diseases
The Canadian Institute for the Relief of Pain and Disability (CIRPD) (in partnership with AUTO21 Network of Centres of Excellence Cross discipline research in:
Mitigating Occupant Injury in Motor Vehicle Collisions
Prevention of Disability Resulting from Vehicular Injuries
Work Rehabilitation and Redesign
Canadian Chiropractic Research Foundation Research to enhance natural approaches to improving and maintaining health and wellness
Research into special areas such as headaches, joint pain/pathologies and dysfunction spanning the life cycle and diagnostic and screening procedures in order to reduce the burden of neuro-musculoskeletal disorders across the Canadian population.
Research into the causes and effects of aging and progressive degeneration of the body
Research to address effective chiropractic healthcare delivery
Huntington Society of Canada Research in Huntington Disease
CNIB E.A. Baker Foundation Vision loss and/or its prevention, rehabilitation and adjustment
Epilepsy Canada Epilepsy
Jewish Rehabilitation Hospital Foundation Pediatric Rehabilitation
Geriatric Rehabilitation
Vestibular Rehabilitation
Neuropsychology
Assistive Technology
Telemedicine
Telesurveillance
Parkwood Hospital Research Foundation rehabilitation research
Saskatoon City Hospital Foundation -- Hader Scholarship in MS Research The cause, pathological mechanism, possible new treatments or treatment outcomes of Multiple Sclerosis.
Canadian Digestive Health Foundation Studies of Gastrointestinal physiology / Pathophysiology and Nutrition.

Genetics

Canadian Fanconi Anemia Research Fund (Fanconi Canada)

Area of Research

The Fanconi Canada/CIHR Fellowship Award will be offered to candidates who will be undertaking full-time research training in Fanconi anemia (FA) research in furtherance of an effective treatment and, ultimately, a cure for Fanconi Anemia (FA).

FA is a rare and fatal genetic disease which generally leads to severe bone marrow failure. Patients are at increased risk for development of solid tumour cancers and leukemias. FA research is ongoing in the areas of improved bone marrow transplants, drug therapies, gene therapy, DNA repair and cancer therapies. This research holds promise not only for FA patients but those afflicted by cancers, leukemias, blood disorders and congenital anomalies.

Program(s) and #s of awards
1 Fellowship

Special Conditions (if any)
The competition is open to candidates with a PhD degree. The award must be held in Canada.

Fragile X Research Foundation of Canada

Area of Research

The FXRFC/CIHR Fellowship Award will be offered to candidates who will be undertaking full-time research training in Fragile X research with an emphasis on the following:,

  • Gene Therapy - Studying the gene that causes Fragile X in order to determine how a healthy gene may be inserted into affected cells, thereby replacing the mutated ineffectual gene, or how the inactive gene might be re-activated.
  • Protein Replacement Therapy - Studying the protein that is lacking due to the mutation, so that the protein may be introduced from an external source to alleviate some of the cognitive and behavioural symptoms.
  • Psychopharmacology - Compensating for the neural deficits and treating the symptoms of Fragile X with medications.
  • Nootropic agents ("smart drugs") - The clinical features of both fragile X and autism suggest global deficits in the brain, which are likely to involve glutamate systems. There is also decreased expression of AMPA receptors in FMR1 knockout mice. Further exploration of the mechanisms underlying the effects of drugs such as Ampakines or other agents that facilitate AMPA transmission, would be highly desirable.
  • The MAP1B connection - Convergence of several studies point to overproduction of MAP1B as a prominent factor in the pathophysiology of Fragile X. The FXRFC is interested in pursuing drug discovery projects, which may utilize inhibition of MAP1B as a primary therapeutic strategy. There is some evidence that MAP1A and MAP2 may also be involved, so further work in delineating the precise defect resulting from over expression of this family of proteins is also a high priority.
  • The mGluR hypothesis - Fragile X knockout mice have excessive hippocampal long-term synaptic depression (LTD). The particular type of LTD involved requires protein synthesis and is mediated by group I metabotropic glutamate receptors (mGluRs). mGluR5 appears to account for most of this mechanism, although the contribution of mGluR1 requires further elaboration. The group 1 metabotropic glutamate receptor antagonists are an exciting near-term therapeutic possibility. Further research to follow up this lead is the FXRFC's highest priority at this time.

Program(s) and #s of awards
4 Fellowships

Special Conditions (if any)
The maximum period of support is three years.

Infection and Immunity

Canadian Foundation Louis Pasteur

Area of Research

Infectious diseases - working in microbiology, infectious diseases, HIV/AIDS or any other directly related subjects including host-response to infectious diseases

Program(s) and #s of awards
1 Fellowship

Special Conditions (if any)
The award must be held under the supervision of a researcher at Institut Pasteur in Paris working in infectious diseases.

Musculoskeletal Health and Arthritis

The Canadian Institute for the Relief of Pain and Disability (CIRPD) (in partnership with AUTO21 Network of Centres of Excellence)

Area of Research

Cross discipline research is encouraged in the following areas:
. Mitigating Occupant Injury in Motor Vehicle Collisions
. Prevention of Disability Resulting from Vehicular Injuries
The research focus must address one of the following areas related to the above themes:
a. advances in injury prevention
b. effective situational diagnosis and management
c. reliable and valid measurement tools to evaluate and improve safety design methodologies, and future research
d. effective research dissemination and utilization practices
e. design methodologies targeted at reducing impairment and disability.

Program(s) and #s of awards
3 Doctoral Research Awards
2 Fellowships

Special Conditions (if any)
Applicants would also be expected to work under the supervision of eligible AUTO21 investigators (www.auto21.ca go to Research Tab). There are 220 researchers participating through 32 Universities across Canada. Awards are for a maximum three year duration

Canadian Chiropractic Research Foundation
Area of Research

  • Research to enhance natural approaches to improving and maintaining health and wellness including but not limited to spinal manipulation, exercise therapy, clinical nutrition, acupuncture/acupressure, psychology and social economic issues.
  • Research into special areas such as headaches, joint pain/pathologies and dysfunction spanning the life cycle and diagnostic and screening procedures in order to reduce the burden of neuro-musculoskeletal disorders across the Canadian population.
  • Research into the causes and effects of aging and progressive degeneration of the body, addressing prevention, treatment and restoration and enhancement of function and body mobility and active living.
  • Research to address effective chiropractic healthcare delivery and its health systems and population-based application with emphasis on reducing the burdens of illness, injury and disability.

Program(s) and #s of awards
Fellowship (A minimum of one fellowship is available. Additional awards may be available should funds permit).

Special Conditions (if any)
The candidate must hold a health professional degree (Doctor of Chiropractic) and, at the time of taking up the award, must either be in their final year of a PhD program at a Canadian university or already hold a PhD.

The award is only tenable at a Canadian university or a Canadian research institute affiliated with a Canadian university

The period of support is for 1 year, although an extension of the award for a further one year is possible on the recommendation of the peer review committee and approval of both funding partners."

Neurosciences, Mental Health and Addiction

Huntington Society of Canada

Area of Research

Research in Huntington Disease - Basic or Applied

Program(s) and #s of awards
1 Doctoral Research Award
1 Fellowship

Special Conditions (if any)
The fellowship competition is open to candidates holding a PhD degree.
CNIB E.A. Baker Foundation

Area of Research

Vision loss and/or its prevention, rehabilitation and adjustment

Program(s) and #s of awards
2 Doctoral Research Awards
2 Fellowships

Epilepsy Canada

Area of Research

To develop expertise in clinical and/or basic research related to epilepsy.
This may include Epilepsy, Seizures, Electroencephalography, Pharmacology, Epilepsy Surgery, Gene Function and/or Psychological aspects.

Program(s) and #s of awards
1 Doctoral Research Award
2 Fellowships

Special Conditions (if any)
The awards must be held in Canada
Maximum period of support is 3 years.

Jewish Rehabilitation Hospital Foundation

Area of Research

The research will be located at the Jewish Rehabilitation Hospital located in Laval. Awards will be targeted in the areas of:

  • Pediatric Rehabilitation
  • Geriatric Rehabilitation
  • Vestibular Rehabilitation
  • Neuropsychology
  • Assistive technology
  • Telemedicine, and
  • Telesurveillance

Program(s) and #s of awards
1 Fellowship

Special Conditions (if any)
The maximum period of support is 3 years and will be based on peer review recommendations.

Parkwood Hospital Research Foundation

Area of Research

To undertake full-time training in rehabilitation research either through accredited graduate programs at the University of Western Ontario (eg. Rehabilitation Sciences, Neurosciences, Epidemiology & Biostatistics) or through affiliation with the postgraduate program in Physical Medicine & Rehabilitation.

Program(s) and #s of awards
1 Doctoral Research Award
1 Fellowship

Special Conditions (if any)
The maximum period of support is three years, non-renewable and will be based on peer review recommendations.

Saskatoon City Hospital Foundation -- Hader Scholarship in MS Research

Area of Research

This Doctoral Research Award is designed to support a student studying the cause, pathological mechanism, possible new treatments or treatment outcomes of Multiple Sclerosis. The Research project may be focused on either basic or clinical science.

Program(s) and #s of awards
1 Doctoral Research Award

Special Conditions (if any)
The awardee must be enrolled in a graduate program of University of Saskatchewan and will be supervised by a faculty member of the Cameco MS Neuroscience Research Center. Interested students are encouraged to visit the University of Saskatchewan website to learn more about available research programs, and to contact prospective supervisors.

Nutrition, Metabolism and Diabetes

Canadian Digestive Health Foundation

Area of Research

Studies of Gastrointestinal physiology / Pathophysiology and Nutrition.

Program(s) and #s of awards
2 Doctoral Research Awards (additional awards may be available depending on funding)

Special Conditions (if any)
The awards must be held in Canada. Awards are for a maximum duration of one year.

For information on the Health Research Partnership Fund, contact:

Natalie Carrière, Project Officer
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address locator: 4809A
Ottawa, Ontario K1A 0W9
(613) 841-4147/ ncarriere@cihr-irsc.gc.ca

For information on the HRPF administration (applications or awards), contact:

HRPF Program Coordinator
Research Capacity Development
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address locator: 4809A
Ottawa, Ontario K1A 0W9
(613) 946-0088

Modified: 2007-03-30

Top of Page
Important Notices